Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy

PURPOSE: Most treatments for patients with metastatic melanoma have a low rate of complete regression and thus overall survival in these patients is poor. We have investigated the ability of adoptive cell transfer utilizing autologous, tumor infiltrating lymphocytes to mediate durable complete regre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rosenberg, Steven A., Yang, James C., Sherry, Richard M., Kammula, Udai S., Hughes, Marybeth S., Phan, Giao Q., Citrin, Deborah E., Restifo, Nicholas P., Robbins, Paul F., Wunderlich, John R., Morton, Kathleen E., Laurencot, Carolyn M., Steinberg, Seth M., White, Donald E., Dudley, Mark E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3131487/
https://ncbi.nlm.nih.gov/pubmed/21498393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0116
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares